March 03, 2025

Study Links Androgenetic Alopecia to Increased Depression Risk

Individuals with androgenetic alopecia face an increased risk of depression, with an odds ratio of 1.015, according to a new Mendelian randomization study.

Conexiant

March 03, 2025

More States Fast Track Foreign-Trained Physicians

Since 2023, nine states have waived U.S. residency requirements for some foreign-trained physicians, with more states considering similar changes.

KFF Health News

February 28, 2025

New Study Backs Mohs Surgery for High-Risk cSCC

Mohs surgery was associated with improved outcomes in the treatment of primary high-stage cSCC compared with WLE.

Conexiant

February 27, 2025

Medical Oddities: Aging Hacks, Sperm Inherited Stress, and Lonely Narcissists

Hormones may be the answer to fighting gray hair and wrinkles. Trauma might be inherited from Dad. And narcissists always feel left out, surprise. We look into all this and more.

Conexiant

February 26, 2025

New Medical Malpractice Rules Issued by American Law Institute

The American Law Institute's first restatement of medical malpractice law shifts focus from customary practice to evidence-based medicine.

Conexiant

February 24, 2025

Do Black Female Doctors Die Earlier?

New JAMA Internal Medicine study finds Black female physicians face higher mortality rates than White women in general population.

Conexiant

February 19, 2025

Study Identifies Skin Lipid Biomarkers for Atopic Dermatitis

Reduced levels of protein-bound ceramides at 6 weeks were associated with an increased risk of atopic dermatitis by age 1 year, according to a new study in JACI.

Conexiant

February 19, 2025

Genetic Links to Frontal Fibrosing Alopecia Identified

A genome-wide meta-analysis identified novel genetic interactions between ERAP1 and MHC class I alleles, highlighting their role in frontal fibrosing alopecia susceptibility.

Conexiant

February 19, 2025

Recurrent Hyperpigmented Patches After GLP-1 Therapy: What's Your Diagnosis?

A 62-year-old female developed fixed drug eruption following semaglutide administration, highlighting the importance of recognizing unusual dermatologic reactions during treatment with glucagon-like peptide-1 receptor agonists.

Conexiant